HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-NOV-11 3UGC TITLE STRUCTURAL BASIS OF JAK2 INHIBITION BY THE TYPE II INHIBTOR NVP-BBT594 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 840-1132; COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9DE; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PACG2TTEV KEYWDS SMALL MOLECULE INHIBITOR, ATP BINDING, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.SCHEUFLER,G.A.TAVARES,P.W.MANLEY,C.PISSOT-SOLDERMANN,M.KROEMER REVDAT 5 13-SEP-23 3UGC 1 REMARK SEQADV REVDAT 4 11-APR-18 3UGC 1 COMPND REVDAT 3 29-AUG-12 3UGC 1 JRNL REVDAT 2 04-JUL-12 3UGC 1 HETNAM REVDAT 1 16-MAY-12 3UGC 0 JRNL AUTH R.ANDRAOS,Z.QIAN,D.BONENFANT,J.RUBERT,E.VANGREVELINGHE, JRNL AUTH 2 C.SCHEUFLER,F.MARQUE,C.H.REGNIER,A.DE POVER,H.RYCKELYNCK, JRNL AUTH 3 N.BHAGWAT,P.KOPPIKAR,A.GOEL,L.WYDER,G.TAVARES,F.BAFFERT, JRNL AUTH 4 C.PISSOT-SOLDERMANN,P.W.MANLEY,C.GAUL,H.VOSHOL,R.L.LEVINE, JRNL AUTH 5 W.R.SELLERS,F.HOFMANN,T.RADIMERSKI JRNL TITL MODULATION OF ACTIVATION-LOOP PHOSPHORYLATION BY JAK JRNL TITL 2 INHIBITORS IS BINDING MODE DEPENDENT. JRNL REF CANCER DISCOV V. 2 512 2012 JRNL REFN ISSN 2159-8274 JRNL PMID 22684457 JRNL DOI 10.1158/2159-8290.CD-11-0324 REMARK 2 REMARK 2 RESOLUTION. 1.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.34 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 79050 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3953 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.34 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.38 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.15 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 5733 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2211 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5446 REMARK 3 BIN R VALUE (WORKING SET) : 0.2211 REMARK 3 BIN FREE R VALUE : 0.2213 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 287 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2239 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 275 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.51790 REMARK 3 B22 (A**2) : -0.32350 REMARK 3 B33 (A**2) : 0.84140 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.11300 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.141 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.047 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2404 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3240 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 886 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 67 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 339 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2404 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 287 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3061 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.94 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 65.60 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3UGC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-11. REMARK 100 THE DEPOSITION ID IS D_1000068719. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 79053 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.340 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.42900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2B7A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8M SODIUM MALONATE PH 6.0, 0.1M REMARK 280 GLYCINE-PH 8.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.48500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.69500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.48500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.69500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 838 REMARK 465 SER A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 465 VAL A 1000 REMARK 465 LEU A 1001 REMARK 465 PRO A 1002 REMARK 465 GLN A 1003 REMARK 465 ASP A 1004 REMARK 465 LYS A 1005 REMARK 465 GLU A 1006 REMARK 465 PHE A 1007 REMARK 465 PHE A 1008 REMARK 465 LYS A 1009 REMARK 465 VAL A 1010 REMARK 465 LYS A 1011 REMARK 465 GLU A 1012 REMARK 465 MET A 1130 REMARK 465 ALA A 1131 REMARK 465 GLY A 1132 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 857 CG CD CE NZ REMARK 470 GLN A 872 CG CD OE1 NE2 REMARK 470 GLU A 890 CD OE1 OE2 REMARK 470 GLN A 942 CD OE1 NE2 REMARK 470 THR A 998 OG1 CG2 REMARK 470 GLU A1015 CG CD OE1 OE2 REMARK 470 GLU A1097 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 869 70.65 -116.85 REMARK 500 GLN A 872 25.05 47.99 REMARK 500 THR A 875 -159.90 -129.26 REMARK 500 ARG A 975 -37.27 83.55 REMARK 500 ASP A 994 97.88 -162.81 REMARK 500 THR A 998 64.52 -113.44 REMARK 500 TYR A1050 -33.90 -31.16 REMARK 500 SER A1054 0.87 84.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 046 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MLI A 1202 DBREF 3UGC A 840 1132 UNP O60674 JAK2_HUMAN 840 1132 SEQADV 3UGC GLY A 838 UNP O60674 EXPRESSION TAG SEQADV 3UGC SER A 839 UNP O60674 EXPRESSION TAG SEQADV 3UGC PHE A 1007 UNP O60674 TYR 1007 ENGINEERED MUTATION SEQADV 3UGC PHE A 1008 UNP O60674 TYR 1008 ENGINEERED MUTATION SEQRES 1 A 295 GLY SER ASP PRO THR GLN PHE GLU GLU ARG HIS LEU LYS SEQRES 2 A 295 PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER VAL SEQRES 3 A 295 GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR GLY SEQRES 4 A 295 GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR GLU SEQRES 5 A 295 GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU SEQRES 6 A 295 LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY SEQRES 7 A 295 VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU ILE SEQRES 8 A 295 MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR LEU SEQRES 9 A 295 GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU SEQRES 10 A 295 GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR LEU SEQRES 11 A 295 GLY THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR ARG SEQRES 12 A 295 ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY SEQRES 13 A 295 ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS GLU SEQRES 14 A 295 PHE PHE LYS VAL LYS GLU PRO GLY GLU SER PRO ILE PHE SEQRES 15 A 295 TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SER SEQRES 16 A 295 VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR SEQRES 17 A 295 GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO PRO SEQRES 18 A 295 ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN GLY SEQRES 19 A 295 GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS ASN SEQRES 20 A 295 ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU SEQRES 21 A 295 ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN VAL SEQRES 22 A 295 ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG VAL SEQRES 23 A 295 ASP GLN ILE ARG ASP ASN MET ALA GLY HET 046 A1201 41 HET MLI A1202 7 HETNAM 046 5-{[6-(ACETYLAMINO)PYRIMIDIN-4-YL]OXY}-N-{4-[(4- HETNAM 2 046 METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL) HETNAM 3 046 PHENYL}-2,3-DIHYDRO-1H-INDOLE-1-CARBOXAMIDE HETNAM MLI MALONATE ION FORMUL 2 046 C28 H30 F3 N7 O3 FORMUL 3 MLI C3 H2 O4 2- FORMUL 4 HOH *275(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 THR A 888 SER A 904 1 17 HELIX 3 3 TYR A 918 ARG A 923 1 6 HELIX 4 4 SER A 936 HIS A 944 1 9 HELIX 5 5 LYS A 945 ILE A 948 5 4 HELIX 6 6 ASP A 949 LYS A 970 1 22 HELIX 7 7 ALA A 978 ARG A 980 5 3 HELIX 8 8 SER A 1016 TYR A 1021 5 6 HELIX 9 9 ALA A 1022 SER A 1029 1 8 HELIX 10 10 SER A 1032 TYR A 1050 1 19 HELIX 11 11 SER A 1056 GLY A 1066 1 11 HELIX 12 12 GLY A 1071 ASN A 1084 1 14 HELIX 13 13 PRO A 1095 TRP A 1106 1 12 HELIX 14 14 ASN A 1109 ARG A 1113 5 5 HELIX 15 15 SER A 1115 ASN A 1129 1 15 SHEET 1 A 5 LEU A 849 LYS A 857 0 SHEET 2 A 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 A 5 GLU A 877 LEU A 884 -1 O GLU A 877 N TYR A 868 SHEET 4 A 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 A 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928 SHEET 1 B 2 ILE A 982 ASN A 986 0 SHEET 2 B 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SITE 1 AC1 24 LEU A 855 VAL A 863 ALA A 880 GLU A 898 SITE 2 AC1 24 LEU A 902 LEU A 905 ILE A 910 VAL A 911 SITE 3 AC1 24 LEU A 927 MET A 929 GLU A 930 TYR A 931 SITE 4 AC1 24 LEU A 932 GLY A 935 LEU A 967 ILE A 973 SITE 5 AC1 24 HIS A 974 LEU A 983 ILE A 992 GLY A 993 SITE 6 AC1 24 ASP A 994 PHE A 995 HOH A1319 HOH A1370 SITE 1 AC2 9 SER A1115 ARG A1117 HOH A1383 HOH A1384 SITE 2 AC2 9 HOH A1385 HOH A1414 HOH A1441 HOH A1503 SITE 3 AC2 9 HOH A1566 CRYST1 106.970 69.390 50.800 90.00 98.98 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009348 0.000000 0.001477 0.00000 SCALE2 0.000000 0.014411 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019929 0.00000